[An HGPRT defective mouse lung cancer cell line and its biological characteristics.].
To provide antigenic cells suitable for cell fusion to preparing lung cancer vaccine. An HGPRT (hypoxanthine guanidine phosphoribosyl transferase)-defective cell line , ALA9702 , was gradually induced by 8-azaguanine (8-AG) from mouse lung cancer cell line , LA795 . The biological characteristics and carcinogenicity of ALA9702 cells have been appraised both in vivo and in vitro. ALA9702 cells have been cultured over one year in medium containing 20mug/ml 8-AG, and maintained their biologic characteristics and carcinogenicity of the original cells , LA795 cells. ALA9702 cell line presents as stabile HGPRT-defective mouse lung cancer cell. It will provide useful antigenic cells for establishment of effective specific lung cancer vaccine therapy.